Cleared Traditional

K212593 - ViaCath, AcQRate Dx Steerable Catheter (FDA 510(k) Clearance)

Oct 2021
Decision
60d
Days
Class 2
Risk

K212593 is an FDA 510(k) clearance for the ViaCath, AcQRate Dx Steerable Catheter. This device is classified as a Catheter, Electrode Recording, Or Probe, Electrode Recording (Class II - Special Controls, product code DRF).

Submitted by Biotronick, Inc. (Lake Oswego, US). The FDA issued a Cleared decision on October 15, 2021, 60 days after receiving the submission on August 16, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1220.

Submission Details

510(k) Number K212593 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 16, 2021
Decision Date October 15, 2021
Days to Decision 60 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DRF - Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1220

Similar Devices - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 14
Vision-MR™ Diagnostic Catheter
K252794 · Imricor Medical Systems, Inc. · Jan 2026
MAGiC Sweep™ EP Mapping Catheter
K250590 · Stereotaxis, Inc. · Jul 2025
VIKING™ Fixed Curve Diagnostic Catheter
K250310 · Boston Scientific Corporation · Jun 2025
EP•XT™ Unidirectional Steerable Diagnostic Catheter
K240366 · Boston Scientific Corporation · Nov 2024
Cosine-10TM Diagnostic Catheter
K233397 · Medtronic, Inc. · Dec 2023
Polaris X™ Unidirectional Steerable Diagnostic Catheter
K233207 · Boston Scientific Corporation · Oct 2023